血糖測試條市場規模、佔有率、成長分析、按應用、按最終用途、按技術、按地區 - 行業預測，2024-2031 年

2022年全球血糖試紙市場規模將為156億美元，預測期內（2024-2031年）複合年成長率為8.1%，從2023年的168.6億美元增加到2031年的314.5億美元。

根據國際糖尿病聯盟稱，全球血糖試紙市場對於糖尿病管理至關重要，由於糖尿病盛行率不斷上升，該市場正在持續成長，預計到 2045 年糖尿病將影響 7 億成年人。糖尿病患者數量的快速增加推動了對血糖試紙的需求，這對於有效監測至關重要。此外，向先進血糖監測系統的顯著轉變，例如連續血糖監測 (CGM) 設備，它提供即時追蹤並減少對傳統指尖採血測試的依賴。儘管CGM 技術日益普及，但血糖試紙由於其價格實惠且易於使用，仍然是自我監測的首選，並且是傳統糖尿病管理解決方案和先進糖尿病管理解決方案的結合，這兩種糖尿病管理解決方案仍然是一個強大的市場。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

血糖測量條市場規模：依應用與複合年成長率（2024-2031）

• 市場概況
• 類型1
• 2型
• 妊娠糖尿病
• 糖尿病前期

血糖測量條市場規模：依最終用途及複合年成長率（2024-2031）

• 市場概況
• 個人
• 醫院和診所
• 其他

血糖測量條市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 葡萄糖脫氫酶（GDH）
• 葡萄糖氧化酵素
• 其他

按地區分類的血糖測量條市場規模和複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

結論和建議

Global Blood Glucose Test Strips Market size was valued at USD 15.6 billion in 2022 and is poised to grow from USD 16.86 billion in 2023 to USD 31.45 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The global blood glucose test strips market is essential to diabetes management, experiencing consistent growth due to the rising prevalence of diabetes, projected to affect 700 million adults by 2045, according to the International Diabetes Federation. This surge in diabetes cases drives demand for blood glucose test strips, vital for effective monitoring. Additionally, there's a notable shift toward advanced glucose monitoring systems like continuous glucose monitoring (CGM) devices, which offer real-time tracking and reduce the reliance on traditional fingerstick testing. Despite the increasing popularity of CGM technologies, blood glucose test strips remain the preferred choice for self-monitoring due to their affordability and ease of use, indicating a continued strong market for both traditional and advanced diabetes management solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Test Strips Market Segmental Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology and Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing significant growth, driven by heightened awareness of the importance of diabetes management and increased healthcare spending. As both governments and healthcare organizations globally prioritize early detection and effective treatment of diabetes, there is a corresponding rise in the adoption of glucose monitoring devices. This focus on improving patient outcomes has led to a surge in demand for blood glucose test strips, as individuals and healthcare providers alike recognize their essential role in managing diabetes effectively. Overall, this combination of awareness and investment in healthcare is propelling the market forward.

Restraints in the Global Blood Glucose Test Strips Market

The Global Blood Glucose Test Strips market faces significant challenges due to the rise of alternative monitoring methods, particularly continuous glucose monitoring (CGM) systems. These advanced technologies provide users with real-time glucose readings, minimizing the need for frequent fingerstick tests and enhancing convenience in monitoring blood sugar levels. As more patients and healthcare providers recognize the benefits of CGM systems, the demand for traditional blood glucose test strips may decline. Consequently, this shift towards more sophisticated and comprehensive glucose monitoring solutions could severely impact the market's growth and profitability, posing a notable restraint for blood glucose test strips manufacturers.

Market Trends of the Global Blood Glucose Test Strips Market

The global blood glucose test strips market is experiencing a notable shift towards continuous glucose monitoring (CGM) systems, driven by increasing consumer demand for efficient and convenient glucose management solutions. With advancements in sensor technology, CGMs allow for real-time tracking of blood glucose levels, significantly reducing the reliance on traditional fingerstick tests. This trend is further fueled by rising awareness among diabetes patients regarding the benefits of continuous monitoring, such as enhanced accuracy and the ability to make timely health decisions. As a result, manufacturers are innovating to integrate CGM capabilities, positioning themselves to cater to the evolving preferences of health-conscious consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2024-2031)

• Market Overview
• Type 1
• Type 2
• Gestational Diabetes
• Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Individuals
• Hospitals and Clinics
• Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Glucose Dehydrogenase (GDH)
• Glucose Oxidase
• Others

Global Blood Glucose Test Strips Market Size & CAGR (2024-2031)

• North America (Application, End Use, Technology)
  • USA
  • Canada
• Europe (Application, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations